Monographs: Dosage forms: Specific monographs: Nitrofurantoin tablets (Nitrofurantoini compressi)

Category. Antibacterial drug.

Additional information Strength in the current, WHO Model list of essential medicines: 100 mg.

Nitrofurantoin tablets may have an enteric sugar coating.

Requirements

Comply with the monograph for "Tablets".

Nitrofurantoin tablets contain not less than 90.0% and not more than 110.0% of the amount of C8H6N4O5 stated on the label.

Identity tests

• Either test A alone or tests B and C may be applied.

A. To a quantity of the powdered tablets equivalent to 0.1 g of Nitrofurantoin add 10 mL of acetic acid (~300 g/l) TS, boil for a few minutes, and filter while hot. Cool to room temperature, collect the precipitate, and dry at 105 °C for 1 hour. Carry out the examination with the residue as described under 1.7 Spectrophotometry in the infrared region. The infrared absorption spectrum is concordant with the spectrum obtained from nitrofurantoin RS or with the reference spectrum of nitrofurantoin.

B. Carry out the test in subdued light.

The absorption spectrum of the final solution obtained in the "Assay", when observed between 220 nm and 400 nm, exhibits two maxima at about 266 nm and 367 nm. The ratio of the absorbance at 367 nm to that at 266 nm is between 1.36 and 1.42.

C. To a quantity of the powdered tablets equivalent to 25 mg of Nitrofurantoin add a mixture of 25 mL of water and 1 mL of ammonia (~260 g/l) TS, shake, and filter; a yellow-orange colour is produced. Add 5 mL of silver nitrate (40 g/l) TS; a yellow precipitate is produced (distinction from furazolidone and nitrofural).

Related substances. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography, using silica gel R2 as the coating substance and a mixture of 9 volumes of nitromethane R and 1 volume of methanol R as the mobile phase. Apply separately to the plate 10 μl of each of the following two solutions. For solution (A) shake a quantity of the powdered tablets equivalent to 0.1 g of Nitrofurantoin with 10 mL of a mixture of 1 volume of dimethylformamide R and 9 volumes of acetone R, filter, and use the clear filtrate. For solution (B) dilute 1 mL of solution A to 100 mL with acetone R. After removing the plate from the chromatographic chamber, allow it to dry in air, heat it at 105 °C for 5 minutes, and examine the chromatogram in ultraviolet light (254 nm). Spray the warm plate with phenylhydrazine/hydrochloric acid TS, heat it again at 105 °C for 10 minutes, and examine the chromatogram in daylight.

By either method of visualization any spot obtained with solution A, other than the principal spot, is not more intense than that obtained with solution B.

Assay

The operations described below must be carried out in subdued light.

Weigh and powder 20 tablets. Add a quantity of the powder equivalent to about 0.12 g of Nitrofurantoin, accurately weighed, to 50 mL of dimethylformamide R, shake for 5 minutes, and add sufficient water to produce 1000 mL. Mix and dilute 5 mL to 100 mL with an aqueous solution containing 1.8 g of sodium acetate R and 0.14 mL of glacial acetic acid R in 100 mL, and filter.

Measure the absorbance of the filtrate in a 1-cm layer at the maximum at about 367 nm, using as the blank the mixture as prepared above of sodium acetate and glacial acetic acid. Calculate the content of C8H6N4O5, using the absorptivity value of 76.5 ( = 765).

to previous sectionto next section